SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-011612
Filing Date
2019-10-10
Accepted
2019-10-10 17:19:36
Documents
4
Period of Report
2019-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mslp_8k.htm 8-K 40810
2 SECURED REVOLVING PROMISSORY NOTE mslp_ex101.htm EX-10.1 83276
3 SECURITY AGREEMENT mslp_ex102.htm EX-10.2 86839
4 LETTER AGREEMENT mslp_ex991.htm EX-99.1 13752
  Complete submission text file 0001654954-19-011612.txt   226011
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 191146683
SIC: 2834 Pharmaceutical Preparations